by | Jan 28, 2025 | Sibley, Laurence, Uddin, Taher
— Published date: 1/29/2025
Value Proposition: New chemical matter that blocks protein synthesis, eliminating infection and providing improved treatment for Toxoplasmosis.
Technology Description
Researchers at Washington University in St. Louis have identified a new chemical matter that can inh…
by | Aug 21, 2020 | Sibley, Laurence
— Plasmids for expression of phenyl alanine tRNA synthase from Toxoplasma gondii, Plasmodium falciparum and Homo sapiens. These include wild type and various mutant forms.
by | Feb 15, 2020 | Sibley, Laurence
— Polyclonal or monoclonal antibodies against Toxoplasma gondii proteins (ROP1, ROP5, GRA7)
Mouse anti-body ROP1 publication: Localization of a Toxoplasma gondii Rhoptry Protein by Immunoelectron Microscopy During and After Host Cell Penetration
Polyclonal rabbit antibody ROP5 publication: Virulence…
by | Nov 27, 2019 | Sibley, Laurence
— The inventors have generated multiple gene knockout strains of T. gondii, listed below.
RH∆hx∆ku80 TIR1 (RH∆ku80∆hxgprt/pTub 5’UTR-OsTir1-3xFlag-DHFR 3’UTR-CAT):
The inventors used the CRISPR/Cas9 system for genome editing, comined with the AID degradation system to generate th…
by | Nov 27, 2019 | Sibley, Laurence
— 2 murine hybridoma cell lines producing antibodies agains Toxoplasma gondii proteins SAG1 and MIC2
SAG1 (DG52) publication: Molecular analysis of the gene encoding the major surface antigen of Toxoplasma gondii
MIC2 (6D10) publication: The Toxoplasma Adhesive Protein MIC2 Is Proteolytically Proces…
by | Nov 21, 2019 | Sibley, Laurence
— This human cell line is a generic source for culturing Toxoplasma gondii in the laboratory. It was generated by Michael White’s laboratory.